Daniel Bronder

🇪🇺🇩🇪 Postdoc @sloan_kettering interested in #aneuploidy, #CIN, #cytosolicDNA, #TumorEvolution. Previously @OfficialUoM & @NCIResearchCtr. All views my own.

[Kristoffer H. J. @KrisHaurum]

Thrilled to share our new paper in @ScienceMagazine! 💥
We developed a computational platform to design tiny 'minibinders' from scratch that can guide T cells to kill cancer cells. This is proof-of-concept for targeting intracellular cancer antigens with a new modality! 🎯

[Daniel Bronder @danielkbronder]

@KrisHaurum @ScienceMagazine Let’s gooo, Kris! 🚀

[Pablo Guasp @PabloGuasp]

I am excited to share our new work on personalized mRNA vaccines in pancreatic cancer in @Nature: https://t.co/yNKV0637XK
Great thread below by @TheVinodLab explaining the findings. As always, it is a pleasure to be part of this team with such great colleagues and friends.

[Daniel Bronder @danielkbronder]

@RRomero_PhD @NatureCancer @SawyersLabMSKCC @dana_peer @HHMINEWS Congrats on getting it out there!

[Eytan Ruppin, MD, PhD @EytanRuppin]

Gliomas play their cards right! Our paper about the mysterious co-occurrence of chromosome 10 loss and 7 gain in #gliomas in now out in @CR_AACR! #BrainCancers@Nishanth_UN @AlejandroSchaf6 @EMichaelGertz @BenDavidLab (1/n)
https://t.co/QElZUrSM5a

[Duaa Al-Rawi, MD PhD @RawiDuaa]

Excited to share that our review on the clinical implications of CIN is out! This is particularly relevant for our patients with high grade serous ovarian cancer. @TeamOvary_MSK @ocrahope

[Lawrence T Wang @Lawreate7]

We co-published b2b papers describing >400 human monoclonal antibodies against the malaria blood-stage antigen RH5! These data will guide testing of current RH5-based vaccines in Africa and improvement of future vaccine candidates.

https://t.co/ldnyVG4dPg
https://t.co/1z5dLhIeSp

[Daniel Bronder @danielkbronder]

@sarahlaing18 I am sure you crushed it, Sarah! I am sure the stunning opening slide was second to the data

[Cancer Cell @Cancer_Cell]

RNA vaccines for cancer: Principles to practice https://t.co/OlpMXbdH4d

[Anahit Mkrtchian @AnahitMkr]

✨New preprint out✨
We examined motivational dysfunction in depression, aiming to dissect which cognitive processes drive impaired effort-based decision making. Through an extensive computational analysis - by the expert @vincentvalton🧠💫- we find a somewhat surprising answer👇

[Daniel Bronder @danielkbronder]

@McclellandLab It's a dying art!

[Pablo Guasp @PabloGuasp]

Exciting times for cancer vaccines as mRNA leads the charge! Insights from vaccines against pathogens pave the way for personalized cancer vaccination. @CharReiche, Zachary Sethna, @TheVinodLab, and myself discuss this and much more in our newly published review in @Cancer_Cell

[Daniel Bronder @danielkbronder]

@robhynds @SwantonLab @NatureComms @AMIHuebner @uclcancer @TheCrick @CRUK_MI Many congrats, Rob! Can’t wait to download the NSG reference and use it

[Daniel Bronder @danielkbronder]

@NicholasAder Congrats!

[Daniel Bronder @danielkbronder]

@TheAlliance05 @NIHOxCam @Gates_Cambridge @rhodes_trust @AstraZeneca Amazing to see!

[Alvaro Quintanal-Villalonga @AlvaroQuintanal]

Looking forward to the amazing talks by very talented @MSKEducation PostBac Bridge Scholars. 1-2 years of work in outstanding @MSKCancerCenter labs in diverse research areas. The nextgen of young investigators is here! Don't miss the date! #MSKBridge

[Cancer Discovery @CD_AACR]

#OnlineFirst: Molecular Determinants of Sensitivity to Polatuzumab Vedotin in Diffuse Large B Cell Lymphoma, by @S_Corcoran, Daniel Hodson, @LouisStaudt et al.
https://t.co/NqlsjsxIX5
@theNCI @NCIResearchCtr @SCICambridge @Cambridge_Uni

[Daniel Bronder @danielkbronder]

My alma mater @UofGMVLS and home city's medical school @MHH_life collaborating!

[University of Glasgow @UofGlasgow]

Today we were delighted to welcome a delegation from the Lower Saxony State in Germany, including representatives from Government, Parliament & the HE sector.

@UofGMVLS & Hannover Medical School signed an MoU and we look forward to further developing collaborations in research.

[Lawrence T Wang @Lawreate7]

Phase II trial where monoclonal antibody L9LS protected 60-70% of children in Mali against malaria for 6mo! Dream come true to see something I pipetted translate into protecting at-risk kids. Can’t wait for the phase III data!

#WorldMalariaDay2024

https://t.co/aK08F9hvdx